Claventin Safety Questions, Claventin Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Claventin side effects. Check out Health Surveys and Health Polls. If you have questions about Claventin, you can post them to our Doctors or Ask Patient Community about Claventin.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Claventin
Claventin Safety Reports
Total Claventin reports: 9.Claventin FDA safety alerts: No.
Reported deaths: 1 Reported hospitalizations: 9.
Take Claventin Side Effects Survey or Share Your Claventin Story.
Reported Claventin Side Effects: blood lactate dehydrogenase increased, aspartate aminotransferase increased, alanine aminotransferase increased, prothrombin level decreased, hyperkalaemia, hepatocellular damage, cardiac failure congestive, renal failure acute, blood creatinine increased, skin exfoliation, skin burning sensation.
More About Claventin.
Claventin Side Effects Report #5249856-3
Consumer or non-health professional from FRANCE reported CLAVENTIN problem on Feb 19, 2007. Male patient, 56 years of age, weighting 127.9 lb, was diagnosed with lung infection, essential hypertension and was treated with CLAVENTIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, cholestasis, gamma-glutamyltransferase increased. CLAVENTIN dosage: unknown. During the same period patient was treated with BACTRIM, TRIATEC, LASIX, OMEPRAZOLE, LOVENOX. Patient was hospitalized. Patient recovered.
Claventin Side Effects Report #5256490-8
CLAVENTIN problem was reported by a Consumer or non-health professional from FRANCE on Feb 28, 2007. Female patient, 60 years of age, was diagnosed with lung abscess and was treated with CLAVENTIN. After drug was administered, patient experienced the following problems/side effects: face oedema, perivascular dermatitis, rash maculo-papular, skin burning sensation, skin exfoliation. CLAVENTIN dosage: unknown. During the same period patient was treated with TILDIEM, FLAGYL, ROCEPHIN, NOVOMIX. Patient was hospitalized. Patient recovered.
Claventin Side Effects Report #5275773-9
Consumer or non-health professional from FRANCE reported CLAVENTIN problem on Mar 22, 2007. Female patient, 60 years of age, was diagnosed with lung abscess and was treated with CLAVENTIN. After drug was administered, patient experienced the following problems/side effects: face oedema, perivascular dermatitis, rash maculo-papular, skin burning sensation, skin exfoliation. CLAVENTIN dosage: unknown. During the same period patient was treated with TILDIEM, FLAGYL, ROCEPHIN, NOVOMIX. Patient was hospitalized. Patient recovered.
Claventin Side Effects Report #5278615-0
CLAVENTIN problem was reported by a Consumer or non-health professional from FRANCE on Mar 22, 2007. Male patient, 60 years of age, was diagnosed with hyperthermia, hypertension, acute myeloid leukaemia and was treated with CLAVENTIN. After drug was administered, patient experienced the following problems/side effects: biopsy kidney abnormal, blood creatinine increased, renal failure acute, urinary retention. CLAVENTIN dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, TARGOCID, NISIS, VFEND, ZOPHREN, ARACYTINE, CERUBIDINE, CEFTRIAXONE. Patient was hospitalized. Patient recovered.
Claventin Side Effects Report #5302117-6
Consumer or non-health professional from FRANCE reported CLAVENTIN problem on Apr 12, 2007. Female patient, 69 years of age, was diagnosed with pseudomonas infection and was treated with CLAVENTIN. After drug was administered, patient experienced the following problems/side effects: anaemia macrocytic, blood lactate dehydrogenase increased, coombs test positive, haemolytic anaemia, haptoglobin decreased. CLAVENTIN dosage: 600MG PER DAY. During the same period patient was treated with OROCAL, OFLOCET, LANTUS, OMEPRAZOLE, TOPALGIC, FORLAX, BUFLOMEDIL, LANSOYL. Patient was hospitalized. Patient recovered.
Claventin Side Effects Report #5365554-X
CLAVENTIN problem was reported by a Consumer or non-health professional from FRANCE on June 12, 2007. Male patient, 54 years of age, was diagnosed with urinary tract infection and was treated with CLAVENTIN. After drug was administered, patient experienced the following problems/side effects: acne, purpura, skin disorder, skin fragility, skin lesion, toxic skin eruption. CLAVENTIN dosage: unknown. During the same period patient was treated with ERLOTINIB, OMEPRAZOLE, OFLOCET. Patient was hospitalized. Patient died.
Claventin Side Effects Report #5044497-5
Consumer or non-health professional from FRANCE reported CLAVENTIN problem on July 04, 2006. Male patient, 58 years of age, weighting 121.3 lb, was diagnosed with sinusitis and was treated with CLAVENTIN. After drug was administered, patient experienced the following problems/side effects: renal failure acute. CLAVENTIN dosage: unknown. During the same period patient was treated with RAPIFEN, LOVENOX, FUNGIZONE, CATAPRES, PLAVIX, PRAVASTATIN, AMLOR. Patient was hospitalized. Patient recovered.
Claventin Side Effects Report #5075823-9
CLAVENTIN problem was reported by a Consumer or non-health professional from FRANCE on Aug 03, 2006. Female patient, 57 years of age, was treated with CLAVENTIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, cardiac failure congestive, hepatocellular damage, hyperkalaemia, prothrombin level decreased, respiratory distress. CLAVENTIN dosage: unknown. During the same period patient was treated with IMUREL. Patient was hospitalized. Patient recovered.
Claventin Side Effects Report #5168230-1
Consumer or non-health professional from FRANCE reported CLAVENTIN problem on Aug 03, 2006. Female patient, 57 years of age, was treated with CLAVENTIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood lactate dehydrogenase increased, cardiac failure congestive, hepatic failure, hepatocellular damage, hyperkalaemia, prothrombin level decreased. CLAVENTIN dosage: unknown. During the same period patient was treated with IMUREL. Patient was hospitalized. Patient recovered.